Thornton Michael Milos 4
4 · ENDRA Life Sciences Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Thornton Michael Milos
Chief Technology Officer
Transactions
- Purchase
Common Stock
2022-12-09$3.40/sh+1,500$5,100→ 19,139 total
Footnotes (1)
- [F1]On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.